Radicle Calm 24: A Study of Health and Wellness Products on Feelings of Anxiety and Related Health Outcomes
NCT06431074 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 502
Last updated 2025-08-14
Summary
A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on feelings of anxiety and related health outcomes
Conditions
- Anxiety
- Stress
Interventions
- DIETARY_SUPPLEMENT
-
Placebo Control Form 1
Participants will use their Placebo Control Form 1 as directed for a period of 6 weeks.
- DIETARY_SUPPLEMENT
-
Calm Active Study Product 1.1 Usage
Participants will use their Radicle Calm Active Study Product 1.1 as directed for a period of 6 weeks.
- DIETARY_SUPPLEMENT
-
Placebo Control 6.1
Participants will use their Placebo Control 6.1 as directed for a period of 6 weeks.
- DIETARY_SUPPLEMENT
-
Calm Active Study Product 6.1 Usage
Participants will use their Radicle Calm Active Study Product 6.1 as directed for a period of 6 weeks.
Sponsors & Collaborators
-
Radicle Science
lead INDUSTRY
Principal Investigators
-
Emily K. Pauli, PharmD · Radicle Science Inc.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Max Age
- 105 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-05-30
- Primary Completion
- 2025-08-04
- Completion
- 2025-08-11
Countries
- United States
Study Locations
More Related Trials
-
Smartphones Aggravating Anxiety Symptoms
NCT06361342 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Efficacy and Safety of Inhaled NC-107 As Compared to Placebo After 4 Weeks of Treatment in Patients with Anxiety
NCT06656806 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
A Trial of the Effect of CVL-865 on Panic Symptoms Induced by Carbon Dioxide Inhalation in Healthy Subjects
NCT04592536 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate the Beneficial Effects of an Oral Nutritional Supplement Based on Leonurus Cardiaca for the Improvement of Mood and Anxiety
NCT06954038 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety Disorder
NCT00106860 ·Status: COMPLETED ·Phase: PHASE3
-
Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder
NCT07123467 ·Status: RECRUITING ·Phase: PHASE3
-
A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder
NCT00236015 ·Status: COMPLETED ·Phase: PHASE3
-
Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study
NCT03549819 ·Status: UNKNOWN ·Phase: PHASE3
-
EDG004 Treatment of Adult Patients With Generalized Anxiety Disorder (GAD)
NCT02305797 ·Status: COMPLETED ·Phase: PHASE3
-
Phase Ⅲ Clinical Trial of Buagafuran Capsules in the Treatment of GAD
NCT06243614 ·Status: RECRUITING ·Phase: PHASE3
-
Cannabidiol for Anxiety
NCT04267679 ·Status: WITHDRAWN ·Phase: PHASE2
-
Phospholipids as Nutritional Support for Reduction of Anxiety
NCT05837832 ·Status: UNKNOWN ·Phase: NA
-
A Clinical Trial of a Hemp-Derived Cannabidiol Product for Anxiety
NCT04286594 ·Status: TERMINATED ·Phase: PHASE2
-
Perceived Changes in Anxiety Symptom Burden During Treatment With Bryophyllum Pinnatum and Tolerability
NCT04825171 ·Status: COMPLETED ·Phase: PHASE4
-
Primary Care Intervention Strategy for Anxiety Disorders
NCT00347269 ·Status: COMPLETED ·Phase: PHASE4
-
Experimental Medication For the Treatment of Generalized Anxiety Disorder
NCT00097708 ·Status: COMPLETED ·Phase: PHASE3
-
A Study To Evaluate PRX-00023 In Patients With Generalized Anxiety Disorder (GAD)
NCT00248183 ·Status: COMPLETED ·Phase: PHASE3
-
A 10-Week Efficacy and Safety Study for of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder
NCT00236054 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 3 Clinical Trial of Buagafuran Capsules in the Treatment of GAD
NCT06243640 ·Status: RECRUITING ·Phase: PHASE3
-
Drug Treatment Validation of Functional Magnetic Resonance Imaging in Generalized Anxiety Disorder
NCT00662259 ·Status: COMPLETED ·Phase: PHASE4
-
To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 2 mg
NCT00912145 ·Status: COMPLETED ·Phase: PHASE1
-
Duloxetine vs Placebo in the Treatment of General Anxiety
NCT00475969 ·Status: COMPLETED ·Phase: PHASE3
-
St. John's Wort Vs. Placebo in Obsessive-Compulsive Disorder.
NCT00035438 ·Status: COMPLETED ·Phase: PHASE2
-
Telephone-Based Care Management Program for Individuals With Anxiety Disorders
NCT00158327 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of Pregabalin, Alprazolam, and Placebo in Subjects With Anxiety Prior to Dental Procedure
NCT00245609 ·Status: COMPLETED ·Phase: PHASE2